共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R021019-10mg | 10mg | 现货 |
PJ34 PJ34 |
98% |
|
|
罗恩 | R021019-50mg | 50mg | 现货 |
PJ34 PJ34 |
98% |
|
|
阿拉丁 | P125128-10mg | 10mg | 现货 |
PJ34,PARPl/2 抑制剂 PJ34 |
Moligand™, ≥98% |
|
|
阿拉丁 | P125128-50mg | 50mg | 现货 |
PJ34,PARPl/2 抑制剂 PJ34 |
Moligand™, ≥98% |
|
|
阿拉丁 | P125128-250mg | 250mg | 现货 |
PJ34,PARPl/2 抑制剂 PJ34 |
Moligand™, ≥98% |
|
|
阿拉丁 | P125128-5mg | 5mg | 现货 |
PJ34,PARPl/2 抑制剂 PJ34 |
Moligand™, ≥98% |
|
|
阿拉丁 | P125128-25mg | 25mg | 现货 |
PJ34,PARPl/2 抑制剂 PJ34 |
Moligand™, ≥98% |
|
|
阿拉丁 | P125128-100mg | 100mg | 现货 |
PJ34,PARPl/2 抑制剂 PJ34 |
Moligand™, ≥98% |
|
|
凯为 | JZ007GIX-50mg | 50mg | 现货 |
N-(6-氧代-5,6-二氢菲啶-2-基)-2-(N,N... Acetamide, N-(5,6-dihydro-6-... |
98% |
|
|
凯为 | JZ007GIX-100mg | 100mg | 现货 |
N-(6-氧代-5,6-二氢菲啶-2-基)-2-(N,N... Acetamide, N-(5,6-dihydro-6-... |
98% |
|
|
凯为 | JZ007GIX-250mg | 250mg | 现货 |
N-(6-氧代-5,6-二氢菲啶-2-基)-2-(N,N... Acetamide, N-(5,6-dihydro-6-... |
98% |
|
|
凯为 | JZ007GIX-25mg | 25mg | 现货 |
N-(6-氧代-5,6-二氢菲啶-2-基)-2-(N,N... Acetamide, N-(5,6-dihydro-6-... |
98% |
|
|
凯为 | JZ007GIX-10mg | 10mg | 现货 |
N-(6-氧代-5,6-二氢菲啶-2-基)-2-(N,N... Acetamide, N-(5,6-dihydro-6-... |
98% |
|
|
毕得 | BD559128-50mg | 50mg | 现货 |
2-(二甲氨基)-N-(6-氧代-5,6-二氢菲-2-基... 2-(Dimethylamino)-N-(6-oxo-5... |
98% |
|
|
毕得 | BD559128-100mg | 100mg | 现货 |
2-(二甲氨基)-N-(6-氧代-5,6-二氢菲-2-基... 2-(Dimethylamino)-N-(6-oxo-5... |
98% |
|
|
毕得 | BD559128-250mg | 250mg | 现货 |
2-(二甲氨基)-N-(6-氧代-5,6-二氢菲-2-基... 2-(Dimethylamino)-N-(6-oxo-5... |
98% |
|
|
毕得 | BD559128-25mg | 25mg | 现货 |
2-(二甲氨基)-N-(6-氧代-5,6-二氢菲-2-基... 2-(Dimethylamino)-N-(6-oxo-5... |
98% |
|
|
源叶 | S26643-5mg | 5mg | 期货,请咨询 |
PJ34,PARPl/2 抑制剂 PJ34 |
≥98% |
|
|
源叶 | S26643-10mg | 10mg | 期货,请咨询 |
PJ34,PARPl/2 抑制剂 PJ34 |
≥98% |
|
|
源叶 | S26643-25mg | 25mg | 期货,请咨询 |
PJ34,PARPl/2 抑制剂 PJ34 |
≥98% |
|
|
源叶 | S26643-50mg | 50mg | 期货,请咨询 |
PJ34,PARPl/2 抑制剂 PJ34 |
≥98% |
|
|
源叶 | S26643-100mg | 100mg | 期货,请咨询 |
PJ34,PARPl/2 抑制剂 PJ34 |
≥98% |
|
|
源叶 | S26643-250mg | 250mg | 期货,请咨询 |
PJ34,PARPl/2 抑制剂 PJ34 |
≥98% |
|
|
Target Mol | T6197-10mg | 10mg | 现货 |
化合物 PJ34 PJ34 |
95.05% |
|
|
Target Mol | T6197-50mg | 50mg | 现货 |
化合物 PJ34 PJ34 |
95.05% |
|
|
Target Mol | T6197-100mg | 100mg | 现货 |
化合物 PJ34 PJ34 |
95.05% |
|
|
Target Mol | T6197-25mg | 25mg | 现货 |
化合物 PJ34 PJ34 |
95.05% |
|
|
Am | A857468-100mg | 100mg | 现货 |
PJ34 PJ34 |
98% |
|
|
Am | A857468-50mg | 50mg | 现货 |
PJ34 PJ34 |
98% |
|
|
Am | A857468-25mg | 25mg | 现货 |
PJ34 PJ34 |
98% |
|
|
Am | A857468-5mg | 5mg | 现货 |
PJ34 PJ34 |
98% |
|
|
Am | A857468-10mg | 10mg | 现货 |
PJ34 PJ34 |
98% |
|
|
MCE | HY-13688A-100mg | 100mg | 现货 |
PJ34 PJ34 |
98.01% |
|
|
MCE | HY-13688A-50mg | 50mg | 现货 |
PJ34 PJ34 |
98.01% |
|
|
MCE | HY-13688A-10mM*1mL | 10mM*1mL | 现货 |
PJ34 PJ34 |
98.01% |
|
|
MCE | HY-13688A-10mg | 10mg | 现货 |
PJ34 PJ34 |
98.01% |
|
|
MCE | HY-13688A-5mg | 5mg | 现货 |
PJ34 PJ34 |
98.01% |
|
|